<p>根据 MarketBeat.com 的报道，目前覆盖 Intuitive Surgical, Inc.（纳斯达克代码：ISRG - 获取免费报告）的 26 位分析师对该公司的平均推荐为 “适度买入”。一位股票研究分析师给予该股票卖出评级，七位分析师给予持有评级，十八位分析师给予买入评级。在过去一年中，发布报告的分析师对该股票的平均 12 个月目标价格为 581.9130 美元。</p>
<p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平了道路</li>
</ul>
<p>ISRG 已成为多份研究分析师报告的主题。花旗集团在 3 月 11 日的报告中将 Intuitive Surgical 的评级从 “中性” 上调至 “买入”，并设定 590.00 美元的目标价格。TD Cowen 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价格从 660.00 美元下调至 585.00 美元，并给予该股票 “买入” 评级。华尔街 Zen 在周六的报告中将 Intuitive Surgical 的评级从 “持有” 上调至 “买入”。摩根大通在 4 月 22 日的研究报告中将 Intuitive Surgical 的目标价格从 625.00 美元下调至 550.00 美元，并给予该公司 “增持” 评级。最后，Argus 在 2 月 4 日的研究报告中将 Intuitive Surgical 的目标价格从 630.00 美元下调至 560.00 美元，并给予该公司 “买入” 评级。</p>
<p><strong>查看我们关于 ISRG 的最新研究报告</strong></p>
<h2>内部人士下注</h2>
<ul>
<li>5 只股票在 AI 推动下加速上涨</li>
</ul>
<p>在相关消息中，董事 Amy L. Ladd 在 4 月 28 日的交易中出售了 500 股该股票。该股票以平均价格 473.46 美元出售，总价值为 236,730.00 美元。交易完成后，该董事在公司持有 239 股，价值 113,156.94 美元。此交易代表其持仓减少了 67.66%。该交易已在向 SEC 提交的文件中披露，文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，SVP Patricia L. Wadors 在 2 月 27 日的交易中出售了 220 股该股票。该股票以平均价格 499.71 美元出售，总价值为 109,936.20 美元。此销售的 SEC 文件提供了更多信息。在过去三个月中，内部人士共出售了价值 2,760,359 美元的 5,647 股公司股票。公司内部人士持有公司股票的 0.60%。</p>
<h2>对 Intuitive Surgical 的对冲基金看法</h2>
<p>对冲基金和其他机构投资者最近调整了对该股票的持有。Ashford Capital Management Inc.在第一季度将其在 Intuitive Surgical 的持仓增加了 8.9%。Ashford Capital Management Inc.现在持有 7,777 股该医疗设备提供商的股票，价值 3,585,000 美元，此前在此期间又购买了 634 股。KCM Investment Advisors LLC 在第一季度将其在 Intuitive Surgical 的持仓增加了 7.4%。KCM Investment Advisors LLC 现在持有 1,819 股该医疗设备提供商的股票，价值 839,000 美元，此前在此期间又购买了 125 股。Glen Eagle Advisors LLC 在第一季度将其在 Intuitive Surgical 的持仓增加了 8.2%。Glen Eagle Advisors LLC 现在持有 345 股该医疗设备提供商的股票，价值 159,000 美元，此前在此期间又购买了 26 股。Quantinno Capital Management LP 在第一季度将其在 Intuitive Surgical 的持仓增加了 18.1%。Quantinno Capital Management LP 现在持有 224,448 股该医疗设备提供商的股票，价值 103,469,000 美元，此前在此期间又购买了 34,445 股。最后，Owl Creek Asset Management L.P.在第一季度获得了 Intuitive Surgical 的新股份，价值约 7,869,000 美元。机构投资者和对冲基金持有公司 83.64% 的股票。</p>
<h2>Intuitive Surgical 股票下跌 1.6%</h2>
<ul>
<li>超越生物技术——3 只面向成长型投资者的医疗股票</li>
</ul>
<p>纳斯达克：ISRG 周五开盘价为 421.12 美元。该公司的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 514.04 美元。该公司的市值为 1491.4 亿美元，市盈率为 51.04，PEG 比率为 3.36，贝塔值为 1.51。Intuitive Surgical 的 52 周低点为 417.74 美元，52 周高点为 603.88 美元。</p>
<p>Intuitive Surgical（纳斯达克：ISRG - 获取免费报告）最后一次发布财报是在 4 月 21 日，医疗设备提供商报告每股收益（EPS）为 2.50 美元，超出分析师一致预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而分析师预期为 26.2 亿美元。Intuitive Surgical 的股本回报率为 15.98%，净利润率为 28.15%。与去年同期相比，Intuitive Surgical 的收入增长了 23.0%。在去年同期，该公司每股收益为 1.81 美元。卖方分析师预计 Intuitive Surgical 在当前年度将发布 8.57 美元的每股收益。</p>
<h2>Intuitive Surgical 新闻摘要</h2>
<p>以下是本周影响 Intuitive Surgical 的主要新闻故事：</p>
<ul>
<li>积极情绪：多篇近期文章强调了直觉外科作为医疗保健人工智能繁荣的潜在受益者，认为每一次机器人手术都会产生有价值的数据，从而改善外科医生培训、术中指导和预测分析。手术机器人与人工智能的结合：直觉外科、美敦力和史崔克是医疗繁荣的潜在黑马</li>
<li>积极情绪：Erste Group Bank 的分析师上调了对 ISRG 的 2026 财年和 2027 财年盈利预期，强化了盈利增长能够持续超出市场共识的预期。MarketBeat 对 ISRG 的覆盖</li>
<li>积极情绪：关于达芬奇 5 的报道指出手术增长强劲，系统利用率提高，表明该公司的最新平台仍在外科医生和医院中获得认可。ISRG 的达芬奇 5 能否维持手术和利用率的增长？</li>
<li>中性情绪：几篇乐观的评论文章表示，近期的抛售使得直觉外科对成长型投资者更具吸引力，但这些主要是评论，而非新的公司特定催化剂。直觉外科今年已下跌 20%。华尔街表示现在是买入的时机。</li>
</ul>
<h2>关于直觉外科</h2>
<p>(获取免费报告)</p>
<p>直觉外科成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的动作，从而实现微创手术。直觉的业务集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
<p>除了核心手术平台外，直觉还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师青睐的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 带入 PC 硬件</li>
<li>Peloton 股票在乐观的财报后回吐涨幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

直觉外科

标普健康医疗设备 ETF - SPDR

ISUL

美国医药设备 ETF - iShares

<p>直觉外科（Intuitive Surgical, Inc.）（纳斯达克代码：ISRG）获得了 26 位分析师的 “适度买入” 共识评级。12 个月的平均目标价格为 581.91 美元，其中包括 18 个买入、7 个持有和 1 个卖出建议。最近注意到内部人士的股票出售和机构投资，内部人士在过去三个月内出售了 5,647 股，价值 276 万美元。该股票开盘价为 421.12 美元，下跌 1.6%，市值为 1491.4 亿美元，市盈率为 51.04</p>

<p>Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) have been given an average recommendation of &#34;Moderate Buy&#34; by the twenty-six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and eighteen have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $581.9130.</p>
<div class="lb-trans"><p>根据 MarketBeat.com 的报道，目前覆盖 Intuitive Surgical, Inc.（纳斯达克代码：ISRG - 获取免费报告）的 26 位分析师对该公司的平均推荐为 “适度买入”。一位股票研究分析师给予该股票卖出评级，七位分析师给予持有评级，十八位分析师给予买入评级。在过去一年中，发布报告的分析师对该股票的平均 12 个月目标价格为 581.9130 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平了道路</li>
</ul>
</div><p>ISRG has been the topic of a number of research analyst reports. Citigroup raised Intuitive Surgical from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $590.00 target price on the stock in a report on Wednesday, March 11th. TD Cowen lowered their target price on Intuitive Surgical from $660.00 to $585.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, April 22nd. Wall Street Zen raised Intuitive Surgical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday. JPMorgan Chase &amp; Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an &#34;overweight&#34; rating for the company in a research report on Wednesday, April 22nd. Finally, Argus decreased their price target on Intuitive Surgical from $630.00 to $560.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, February 4th.</p>
<div class="lb-trans"><p>ISRG 已成为多份研究分析师报告的主题。花旗集团在 3 月 11 日的报告中将 Intuitive Surgical 的评级从 “中性” 上调至 “买入”，并设定 590.00 美元的目标价格。TD Cowen 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价格从 660.00 美元下调至 585.00 美元，并给予该股票 “买入” 评级。华尔街 Zen 在周六的报告中将 Intuitive Surgical 的评级从 “持有” 上调至 “买入”。摩根大通在 4 月 22 日的研究报告中将 Intuitive Surgical 的目标价格从 625.00 美元下调至 550.00 美元，并给予该公司 “增持” 评级。最后，Argus 在 2 月 4 日的研究报告中将 Intuitive Surgical 的目标价格从 630.00 美元下调至 560.00 美元，并给予该公司 “买入” 评级。</p>
</div><p><strong>Check Out Our Latest Research Report on ISRG</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ISRG 的最新研究报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>5 Stocks Racing Ahead as AI Supercharges Robotics</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只股票在 AI 推动下加速上涨</li>
</ul>
</div><p>In related news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the transaction, the director owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The SEC filing for this sale provides additional information. Insiders have sold a total of 5,647 shares of company stock worth $2,760,359 over the last three months. Company insiders own 0.60% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Amy L. Ladd 在 4 月 28 日的交易中出售了 500 股该股票。该股票以平均价格 473.46 美元出售，总价值为 236,730.00 美元。交易完成后，该董事在公司持有 239 股，价值 113,156.94 美元。此交易代表其持仓减少了 67.66%。该交易已在向 SEC 提交的文件中披露，文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，SVP Patricia L. Wadors 在 2 月 27 日的交易中出售了 220 股该股票。该股票以平均价格 499.71 美元出售，总价值为 109,936.20 美元。此销售的 SEC 文件提供了更多信息。在过去三个月中，内部人士共出售了价值 2,760,359 美元的 5,647 股公司股票。公司内部人士持有公司股票的 0.60%。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>对 Intuitive Surgical 的对冲基金看法</h2>
</div><p>Hedge funds and other institutional investors have recently modified their holdings of the stock. Ashford Capital Management Inc. boosted its position in Intuitive Surgical by 8.9% during the 1st quarter. Ashford Capital Management Inc. now owns 7,777 shares of the medical equipment provider's stock worth $3,585,000 after acquiring an additional 634 shares during the period. KCM Investment Advisors LLC boosted its position in Intuitive Surgical by 7.4% during the 1st quarter. KCM Investment Advisors LLC now owns 1,819 shares of the medical equipment provider's stock worth $839,000 after acquiring an additional 125 shares during the period. Glen Eagle Advisors LLC boosted its position in Intuitive Surgical by 8.2% during the 1st quarter. Glen Eagle Advisors LLC now owns 345 shares of the medical equipment provider's stock worth $159,000 after acquiring an additional 26 shares during the period. Quantinno Capital Management LP boosted its position in Intuitive Surgical by 18.1% during the 1st quarter. Quantinno Capital Management LP now owns 224,448 shares of the medical equipment provider's stock worth $103,469,000 after acquiring an additional 34,445 shares during the period. Finally, Owl Creek Asset Management L.P. acquired a new stake in Intuitive Surgical during the 1st quarter worth about $7,869,000. Institutional investors and hedge funds own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近调整了对该股票的持有。Ashford Capital Management Inc.在第一季度将其在 Intuitive Surgical 的持仓增加了 8.9%。Ashford Capital Management Inc.现在持有 7,777 股该医疗设备提供商的股票，价值 3,585,000 美元，此前在此期间又购买了 634 股。KCM Investment Advisors LLC 在第一季度将其在 Intuitive Surgical 的持仓增加了 7.4%。KCM Investment Advisors LLC 现在持有 1,819 股该医疗设备提供商的股票，价值 839,000 美元，此前在此期间又购买了 125 股。Glen Eagle Advisors LLC 在第一季度将其在 Intuitive Surgical 的持仓增加了 8.2%。Glen Eagle Advisors LLC 现在持有 345 股该医疗设备提供商的股票，价值 159,000 美元，此前在此期间又购买了 26 股。Quantinno Capital Management LP 在第一季度将其在 Intuitive Surgical 的持仓增加了 18.1%。Quantinno Capital Management LP 现在持有 224,448 股该医疗设备提供商的股票，价值 103,469,000 美元，此前在此期间又购买了 34,445 股。最后，Owl Creek Asset Management L.P.在第一季度获得了 Intuitive Surgical 的新股份，价值约 7,869,000 美元。机构投资者和对冲基金持有公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical Stock Down 1.6%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票下跌 1.6%</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技术——3 只面向成长型投资者的医疗股票</li>
</ul>
</div><p>NASDAQ:ISRG opened at $421.12 on Friday. The business's 50-day moving average price is $463.63 and its 200 day moving average price is $514.04. The firm has a market cap of $149.14 billion, a P/E ratio of 51.04, a PEG ratio of 3.36 and a beta of 1.51. Intuitive Surgical has a 52-week low of $417.74 and a 52-week high of $603.88.</p>
<div class="lb-trans"><p>纳斯达克：ISRG 周五开盘价为 421.12 美元。该公司的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 514.04 美元。该公司的市值为 1491.4 亿美元，市盈率为 51.04，PEG 比率为 3.36，贝塔值为 1.51。Intuitive Surgical 的 52 周低点为 417.74 美元，52 周高点为 603.88 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical's revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.81 earnings per share. Sell-side analysts expect that Intuitive Surgical will post 8.57 EPS for the current year.</p>
<div class="lb-trans"><p>Intuitive Surgical（纳斯达克：ISRG - 获取免费报告）最后一次发布财报是在 4 月 21 日，医疗设备提供商报告每股收益（EPS）为 2.50 美元，超出分析师一致预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而分析师预期为 26.2 亿美元。Intuitive Surgical 的股本回报率为 15.98%，净利润率为 28.15%。与去年同期相比，Intuitive Surgical 的收入增长了 23.0%。在去年同期，该公司每股收益为 1.81 美元。卖方分析师预计 Intuitive Surgical 在当前年度将发布 8.57 美元的每股收益。</p>
</div><h2>Intuitive Surgical News Summary</h2>
<div class="lb-trans"><h2>Intuitive Surgical 新闻摘要</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本周影响 Intuitive Surgical 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom</li>
<li>Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage</li>
<li>Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?</li>
<li>Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：多篇近期文章强调了直觉外科作为医疗保健人工智能繁荣的潜在受益者，认为每一次机器人手术都会产生有价值的数据，从而改善外科医生培训、术中指导和预测分析。手术机器人与人工智能的结合：直觉外科、美敦力和史崔克是医疗繁荣的潜在黑马</li>
<li>积极情绪：Erste Group Bank 的分析师上调了对 ISRG 的 2026 财年和 2027 财年盈利预期，强化了盈利增长能够持续超出市场共识的预期。MarketBeat 对 ISRG 的覆盖</li>
<li>积极情绪：关于达芬奇 5 的报道指出手术增长强劲，系统利用率提高，表明该公司的最新平台仍在外科医生和医院中获得认可。ISRG 的达芬奇 5 能否维持手术和利用率的增长？</li>
<li>中性情绪：几篇乐观的评论文章表示，近期的抛售使得直觉外科对成长型投资者更具吸引力，但这些主要是评论，而非新的公司特定催化剂。直觉外科今年已下跌 20%。华尔街表示现在是买入的时机。</li>
</ul>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>关于直觉外科</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直觉外科成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的动作，从而实现微创手术。直觉的业务集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手术平台外，直觉还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>3 Stocks to Own If Gas Prices Keep Rising</li>
<li>3 Crucial Aerospace Component Makers That Analysts Love</li>
<li>Alphabet's Googlebook Brings Gemini AI to PC Hardware</li>
<li>Peloton Stock Gives Back Gains After Upbeat Earnings Report</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师青睐的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 带入 PC 硬件</li>
<li>Peloton 股票在乐观的财报后回吐涨幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of "Moderate Buy" by Brokerages

Market Beat

GraniteShares 2x Long ISRG Daily ETF

花旗

Toronto Dominion Bank

摩根大通

CITIGROUP INC 6.250 NON CUM SER II PFD WI

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Intuitive Surgical 公司（纳斯达克股票代码：ISRG）被券商一致给予 “适度买入” 评级